Other inflammation markers associated with poor prognosis after cell therapy include leukocytosis, lower levels of IL-10 (anti-inflammatory cytokine enhancing tissue repair), and higher levels of CD45 + inflammatory cells infiltrated in the wound [30, 31]. The gene discussed is IL10; the disease is Increased total leukocyte count.